Kaiser Permanente Study Finds Childhood Diagnosis Of ADHD Increased Dramatically Over Nine-Year Period
This study is part of Kaiser Permanente's broader efforts to deliver transformational health research regarding the impacts of ADHD. One recent Kaiser Permanente study found an association between conditions in which the prenatal brain is deprived of oxygen and the risk of ADHD in children and adults.
And last December, a Kaiser Permanente study found little evidence of increased risk of heart attack, sudden cardiac death or stroke associated with use of medications used primarily to treat ADHD. The population-based study included more than 150,000 adults aged 25 to 64 years who used ADHD medications.
These studies are made possible in part by Kaiser Permanente's extensive electronic health record system, one of the largest private systems in the world. The organization's integrated model and electronic health record system securely connects 9 million people, 611 medical offices, and 37 hospitals, linking patients with their health care teams, their personal health information and the latest medical knowledge. The system coordinates patient care between the physician's office, the hospital, radiology, the laboratory and the pharmacy, and helps eliminate the pitfalls of incomplete, missing, or unreadable charts. It also connects Kaiser Permanente's researchers to one of the most extensive collections of longitudinal and de-identified medical data available, facilitating studies and important medical discoveries that shape the future of health and care delivery for patients and the medical community.
In addition to lead author Dr. Getahun, study authors included Steven J. Jacobsen, MD, PhD, and Wansu Chen of the Kaiser Permanente Southern California Department of Research & Evaluation; Michael J. Fassett, MD, of the Department of Maternal-Fetal Medicine, West Los Angeles Medical Center; and Kitaw Demissie, MD, PhD, and George G. Rhoads, MD, MPH, of the Department of Epidemiology, University of Medicine and Denistry, New Jersey-School of Public Health.About the Kaiser Permanente Southern California Department of Research & Evaluation The Department of Research & Evaluation (R & E) conducts high-quality, innovative research into disease etiology, prevention, treatment and care delivery. Investigators conduct epidemiology, health sciences, and behavioral research as well as clinical trials. Areas of interest include diabetes and obesity, cancer, HIV/AIDS, cardiovascular disease, aging and cognition, pregnancy outcomes, women's and children's health, quality and safety, and pharmacoepidemiology. Located in Pasadena, Calif., the department focuses on translating research to practice quickly to benefit the health and lives of Kaiser Permanente Southern California members and the general population. Visit www.kp.org/research. About Kaiser Permanente Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services to improve the health of our members and the communities we serve. We currently serve more than 9 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to www.kp.org/newscenter. For more information: Vincent Staupe, firstname.lastname@example.org, 415.318.4386 Sandra Hernandez-Millett, email@example.com, 626.405.5384 SOURCE Kaiser Permanente
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV